A2-32-01 is an anti-virulence drug that specifically inhibited ClpP and eliminated both AML cell lines and primary samples with elevated ClpP expression without killing normal haematopoietic cells (74). The gene discussed is CLPP; the disease is acute myeloid leukemia.